Global Drug Abuse Testing Market Growth (Status and Outlook) 2023-2029

Global Drug Abuse Testing Market Growth (Status and Outlook) 2023-2029

Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing.

LPI (LP Information)' newest research report, the “Drug Abuse Testing Industry Forecast” looks at past sales and reviews total world Drug Abuse Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Abuse Testing sales for 2023 through 2029. With Drug Abuse Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Abuse Testing industry.

This Insight Report provides a comprehensive analysis of the global Drug Abuse Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Abuse Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Abuse Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Abuse Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Abuse Testing.

The global Drug Abuse Testing market size is projected to grow from US$ 6010.5 million in 2022 to US$ 9582.5 million in 2029; it is expected to grow at a CAGR of 6.9% from 2023 to 2029.

Illegal drug is non-prescribed type of drug taken for non-medicinal reasons that affects physical and mental health of addicts. There were more than 208 million people consuming illegal drugs worldwide. Change in life style attracts younger people to consume illicit drugs, which is a major driver for this market.Therefore, it is indispensable to screen for drug abuse, to monitor someone with a substance abuse problem, to monitor compliance with prescribed medications, or to detect and evaluate drug intoxication or overdose

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Abuse Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Random Testing
Reasonable Testing
Post accident Testing
Follow-up Testing

Segmentation by application
Schools and Educational Institutes
Hospitals and Healthcare Units
Government and Private Departments

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biomedical Diagnostics
BioMerieux
Abbott
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter

Please note: The report will take approximately 2 business days to prepare and deliver.